ArticlePloS one2026

Editorial Note: Preclinical evaluation of 4-methylthiobutyl isothiocyanate on liver cancer and cancer stem cells with different p53 status.

PLOS One EditorsPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.